SecBot SecBot
SECBOTREPLAY Home › Report › REPL

REPL · Replimune insiders show a mixed cluster: Baker Bros

Replimune Group, Inc. · CLUSTER filed Aug 19, 2026 at 18:42 ET

At the news

MIXEDIMPACT 6/10

CLUSTER filed Aug 19, 2026 at 18:42 ET

Replimune insiders show a mixed cluster: Baker Bros. (10% owner) bought $1.52M in the public offering at $12.06, while the CEO, CFO, CMO, and CAO collectively sold $889K in open-market sales. The CEO/CMO/CAO sales on 8/10 coincided with the $150M dilutive offering priced at $12.06, and the CFO's sale on 8/17 followed the stock's rise to $14.28 after the FDA approval of TUDRIQEV. The Baker Bros. buy is a strong vote of confidence from the largest holder, but the C-suite selling, especially the CEO's $510K sale, creates a bearish signal that partially offsets the bullish approval catalyst.

  • Baker Bros. Advisors LP (10% owner) bought 126,400 shares at $12.06 for $1.52M on 8/11, participating in the $150M public offering.
  • CEO Sushil Patel sold 39,300 shares at $12.97 for $510K on 8/10, the same day the $150M offering was priced.
  • CFO Emily Luisa Hill sold 9,256 shares at $14.28 for $132K on 8/17, after the stock rose post-FDA approval.
  • CMO Konstantinos Xynos sold 11,400 shares at $12.97 for $148K on 8/10.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access